According to G1 Therapeutics 's latest financial reports the company's current EPS (TTM) is -$1.42. In 2022 the company made an earnings per share (EPS) of -$3.37 an increase over its 2021 EPS that were of -$3.53.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.42 | -57.86% |
2022 | -$3.37 | -4.53% |
2021 | -$3.53 | 34.22% |
2020 | -$2.63 | -19.33% |
2019 | -$3.26 | 26.36% |
2018 | -$2.58 | -10.06% |
2017 | -$2.87 | 68.91% |
2016 | -$1.70 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | 53.52% | ๐บ๐ธ USA |